Literature DB >> 10620436

Squamous cell carcinoma of the vulva stage IA: long-term results.

J F Magrina1, J Gonzalez-Bosquet, A L Weaver, T A Gaffey, K O Leslie, M J Webb, K C Podratz.   

Abstract

OBJECTIVE: The aim of this study was to evaluate the risk of metastases to lymph nodes and long-term results of radical and modified radical surgery in patients with a T1 squamous cell carcinoma of the vulva and </=1 mm of invasion.
METHODS: A retrospective review of 40 patients with T1 squamous cell carcinoma of the vulva and </=1 mm of invasion was performed. The clinical, pathologic, surgical, and follow-up data were abstracted from the patients' records. All slides were reviewed by two pathologists according to previously established guidelines. The overall mean follow-up was 7.6 years.
RESULTS: Vulvar recurrence developed in 2 patients (5-year rate, 5.9%). There were no groin recurrences among 10 patients undergoing groin lymphadenectomy. One of the 30 patients (10-year rate, 6.7%) without groin dissection developed groin metastases at 7.5 years, subsequent to an invasive vulvar recurrence. The 5- and 10-year cause-specific survivals were 100 and 94.7%, respectively.
CONCLUSIONS: T1 squamous cell carcinoma of the vulva with </=1 mm of invasion was associated with a low risk of vulvar recurrence and no groin node metastases. A low risk of subsequent groin node metastasis exists in patients developing an invasive vulvar recurrence. Long-term follow-up of these patients is recommended. Lesser forms of vulvar excision, such as wide local excision, were equally effective as radical vulvectomy for the prevention of vulvar recurrences. Patients treated by radical vulvar surgery experienced increased postoperative complications compared with patients treated by less radical surgery. Copyright 2000 Academic Press.

Entities:  

Mesh:

Year:  2000        PMID: 10620436     DOI: 10.1006/gyno.1999.5638

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  5 in total

Review 1.  Challenging the concept of microinvasive carcinoma of the vulva: report of a case with regional lymph node recurrence and review of the literature.

Authors:  Jutta Sidor; Raihana Diallo-Danebrock; Elke Eltze; Ralph J Lellé
Journal:  BMC Cancer       Date:  2006-06-14       Impact factor: 4.430

2.  An alternative way to measure the depth of invasion of vulvar squamous cell carcinoma in relation to prognosis.

Authors:  Loes C G van den Einden; Leon F A G Massuger; Johanna K Jonkman; Peter Bult; Joanne A de Hullu; Johan Bulten
Journal:  Mod Pathol       Date:  2014-09-05       Impact factor: 7.842

3.  [Pathoanatomical preparation and reporting of specimens from precancerous lesions and carcinomas of the vulva].

Authors:  L-C Horn; K Schierle; K Klostermann; H-G Schnürch; P Hantschmann
Journal:  Pathologe       Date:  2009-02       Impact factor: 1.011

4.  Measuring the depth of invasion in vulvar squamous cell carcinoma: interobserver agreement and pitfalls.

Authors:  Anne-Floor W Pouwer; Peter Bult; Irene Otte; Michiel van der Brand; Judith van der Horst; Laurette J V Harterink; Koen K van de Vijver; Esther Guerra; Riena P Aliredjo; Steven L Bosch; Johanna M M Grefte; Saskia Zomer; Harry Hollema; Barry de Heus; Saphira Satumalaij; Patricia C Ewing-Graham; Joanna IntHout; Joanne A de Hullu; Johan Bulten
Journal:  Histopathology       Date:  2019-07-26       Impact factor: 5.087

5.  Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of vulvar cancer and vaginal cancer.

Authors:  Toshiaki Saito; Tsutomu Tabata; Hitoshi Ikushima; Hiroyuki Yanai; Hironori Tashiro; Hitoshi Niikura; Takeo Minaguchi; Toshinari Muramatsu; Tsukasa Baba; Wataru Yamagami; Kazuya Ariyoshi; Kimio Ushijima; Mikio Mikami; Satoru Nagase; Masanori Kaneuchi; Nobuo Yaegashi; Yasuhiro Udagawa; Hidetaka Katabuchi
Journal:  Int J Clin Oncol       Date:  2017-11-20       Impact factor: 3.402

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.